{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/191997637",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/443735651"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1073732465"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#191997637",
  "code": "XM8SX7",
  "source": "http://id.who.int/icd/entity/191997637",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Alpha-adrenoreceptor antagonists"
      },
      "foundationReference": "http://id.who.int/icd/entity/1775563203",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1775563203"
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Peripherally acting antiadrenergic agents"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Peripherally acting antiadrenergic agents"
      }
    }
  ]
}